How is the Ensysce Biosciences Inc today?

The Ensysce Biosciences Inc today is trading in the green, up by 2.40% at 2.13.

How has Ensysce Biosciences Inc performed historically?

The Ensysce Biosciences Inc is currently trading up 2.40% on an intraday basis in the past week the index rose 3.40%. The index has been down -45.10% in the past quarter and rose 287.27% in the past year. You can view this in the overview section.

What is Ensysce Biosciences Inc Annual Net Profit?

Ensysce Biosciences Inc Annual Net Profit rose 24.74% in the last year to $7.99 M. Its sector's average net profit growth for the last fiscal year was -14.04%.

What is Ensysce Biosciences Inc Price to Earning Ratio?

Ensysce Biosciences Inc Price to Earning Ratio is -0.74, which is negative.

What is Ensysce Biosciences Inc Stock Price?

Ensysce Biosciences Inc Stock Price rose 287.27% and underperformed its sector by 139.82% in the past year.

What is Ensysce Biosciences Inc Quarterly Net profit?

Ensysce Biosciences Inc Quarterly Net profit rose 37.57% YoY to $1.95 M. Its sector's average net profit growth YoY for the quarter was -236.05%.

What is Ensysce Biosciences Inc Debt to Equity Ratio?

Ensysce Biosciences Inc Debt to Equity Ratio of 0.08 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Ensysce Biosciences Inc Return on Equity(ROE)?

Ensysce Biosciences Inc Return on Equity(ROE) for the last financial year was -471.84%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Ensysce Biosciences Inc Mutual Fund Holding?

Ensysce Biosciences Inc Mutual Fund Holding decreased by 0.16% in the last quarter to 1.04.

What is Ensysce Biosciences Inc Interest Coverage Ratio?

Ensysce Biosciences Inc Interest Coverage Ratio is -5.19, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Ensysce Biosciences Inc Institutional Holding?

Ensysce Biosciences Inc Institutional Holding increased by 0.38% in the last quarter to 8.96.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
ENSYSCE BIOSCIENCES INC

Ensysce Biosciences Inc XNAS: ENSC

Ensysce Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Ensysce Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Ensysce Biosciences Inc
Rating: 0.72600
Author: Trendlyne DVM scores

about

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overd...

2.13 0.05 (2.40%)

78.44% Fall from 52W High

29,974

XNAS Volume

XNAS 18 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.5 / 100

Technically Bearish

19.5 / 100

No estimates available

Ensysce Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ensysce Biosciences Inc Live Share Price Today, Share Analysis and Chart

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overd...

78.44% Fall from 52W High

SWOT Analysis

Ensysce Biosciences Inc Live Price Chart

Ensysce Biosciences Inc FAQ

How is Ensysce Biosciences Inc today?

Ensysce Biosciences Inc today is trading in the green, and is up by 2.40% at 2.13.

How has Ensysce Biosciences Inc performed historically?

Ensysce Biosciences Inc is currently trading up 2.40% on an intraday basis. In the past week the stock rose 3.40%. stock has been down -45.10% in the past quarter and rose 287.27% in the past year. You can view this in the overview section.